TrialCancer prevention research (Philadelphia, Pa.)2015

A Phase II Randomized, Controlled Trial of S-Adenosylmethionine in Reducing Serum α-Fetoprotein in Patients with Hepatitis C Cirrhosis and Elevated AFP.

Timothy R Morgan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.